Momenta overcomes hurdle to launch generic Copaxone

Momenta Pharmaceuticals reversed a four month stock slide today after a last-ditch lawsuit by a competitor to stave off generic versions of a multiple sclerosis drug failed - despite that fact that Momenta hasn’t revealed when it plans to launch the drug...